CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
1 hedge funds and large institutions have $21.1K invested in Cymabay Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 198 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
1
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$262M | |
| 2 | -$227M | |
| 3 | -$164M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$149M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$144M |
